Involvement of the 5-HT1A receptor of the cuneiform nucleus in the regulation of cardiovascular responses during normal and hemorrhagic conditions

Document Type: Original Article


1 Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

2 Division of Neurocognitive Sciences, Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

3 Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran


Objective(s): The 5-hydroxytryptamine1A (5-HT1A) receptor is one of the serotonin receptors in the brain, which regulates cardiovascular responses, especially in hemorrhage. Presence of this receptor in the cuneiform nucleus (CnF) has been shown. The present study evaluates the cardiovascular effect of this receptor of the CnF in normal and hypotensive hemorrhagic rats.
Materials and Methods: Agonist (8-OH-DPAT) and antagonist (WAY-100635) of 5-HT1A microinjected into the CnF in basal and hemorrhagic conditions and cardiovascular responses were evaluated. Hemorrhage induced by blood withdrawal from the femoral artery and 2 min after that drugs microinjected. Time course and peak changes (∆) of the mean arterial pressure (MAP), systolic blood pressure (SBP) and heart rate (∆HR) were obtained and compared to the control and hemorrhage groups.
Results: In basal condition, 8-OH-DPAT significantly decreased ∆SBP, ∆MAP and ∆HR compared to the control (P<0.05-P<0.01), while way-100635 did not have a significant effect. Hypotension and tachycardia induced by hemorrhage ameliorated by agonist (P<0.05-P<0.01), while antagonist deteriorated hypotension (P<0.05) but attenuated tachycardia (P<0.01).
Conclusion: This study shows that 5-HT1A receptor of the CnF involves in regulation of the cardiovascular responses. However, this effect in basal and hemorrhage conditions is different.


1. Ramage AG, Villalón CM. 5-hydroxytryptamine and cardiovascular regulation. Trend Pharmacol Sci 2008; 29:472-481.
2. Watts SW, Morrison SF, Davis RP, Barman SM. Serotonin and blood pressure regulation. Pharmacol Rev 2012; 64:359-388.
3. Mohammad‐Zadeh L, Moses L, Gwaltney‐Brant S. Serotonin: a review. J Vet Pharmacol Ther 2008; 31:187-199.
4. Dampney RA. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 1994; 74:323-364.
5. McCALL RB, Clement ME. Role of serotonin1A and serotonin2 receptors in the central regulation of the cardiovascular system. Pharmacol Rev 1994; 46:231-243.
6. Scrogin KE, Johnson AK, Brooks VL. Methysergide delays the decompensatory responses to severe hemorrhage by activating 5-HT1A receptors. Am J Physiol Regul Integ Comparat Physiol 2000; 279:1776-1786.
7. Dean C, Bago M. Renal sympathoinhibition mediated by 5-HT1Areceptors in the RVLM during severe hemorrhage in rats. Am J Physiol Regul Integ Comparat Physiol 2002; 282:122-130.
8. Bago M, Dean C. Sympathoinhibition from ventrolateral periaqueductal gray mediated by 5-HT1A receptors in the RVLM. Am J Physiol Regul Integ Comparat Physiol 2001; 280:976-984.
9. Gioia M, Bianchi R. The cytoarchitecture of the nucleus cuneiformis. A Nissl and Golgi study. J Anat 1987; 155:165-176.
10. Lam W, Gundlach AL, Verberne AJ. Increased nerve growth factor inducible-A gene and c-fos messenger RNA levels in the rat midbrain and hindbrain associated with the cardiovascular response to electrical stimulation of the mesencephalic cuneiform nucleus. Neurosci 1996; 71:193-211.
11. Allen LF, Inglis WL, Winn P. Is the cuneiform nucleus a critical component of the mesencephalic locomotor region? An examination of the effects of excitotoxic lesions of the cuneiform nucleus on spontaneous and nucleus accumbens induced locomotion. Brain Res Bull 1996; 41:201-210.
12. Verberne AJ, Lam W, Owens NC, Sartor D. Supramedullary modulation of sympathetic vasomotor function. Clin Exp Pharmacol Physiol 1997; 24:748-754.
13. Pose I, Sampogna S, Chase MH, Morales FR. Cuneiform neurons activated during cholinergically induced active sleep in the cat. J Neurosci 2000; 20:3319-3327.
14. Zemlan FP, Behbehani MM. Nucleus cuneiformis and pain modulation: anatomy and behavioral pharmacology. Brain Res 1988; 453:89-102.
15. Korte SM, Jaarsma D, Luiten PGM, Bohus B. Mesencephalic cuneiform nucleus and its ascending and descending projections serve stress-related cardiovascular responses in the rat. J Auton Nerv Syst 1992; 41:157-176.
16. Lam W, Verberne AJ. Cuneiform nucleus stimulation-induced sympathoexcitation: role of adrenoceptors, excitatory amino acid and serotonin receptors in rat spinal cord. Brain Res 1997; 757:191-201.
17. Shafei MN, Nasimi A. Effect of glutamate stimulation of the cuneiform nucleus on cardiovascular regulation in anesthetized rats: Role of the pontine Kolliker-Fuse nucleus. Brain Res 2011; 1385:135-143.
18. Shafei MN, Niazmand S, Hosseini M, Daloee MH. Pharmacological study of cholinergic system on cardiovascular regulation in the cuneiform nucleus of rat. Neurosci Lett 2013; 549:12-7.
19. Farrokhi E, Shafei MN, Khajavirad A, Hosseini M, Bideskan ARE. Role of the nitrergic system of the cuneiform nucleus in cardiovascular responses in Urethane-Anesthetized male rats. Iran J Med Sci 2017; 42:473-478.
20. Ahlgren J, Porter K, Hayward LF. Hemodynamic responses and c-Fos changes associated with hypotensive hemorrhage: standardizing a protocol for severe hemorrhage in conscious rats. Am J Physiol Regul Integ Comparat Physiol 2007; 292:1862-1871.
21. Buller KM, Smith DW, Day TA. NTS catecholamine cell recruitment by hemorrhage and hypoxia. Neurorep 1999; 10:3853-3856.
22. Thrivikraman KV, Bereiter DA, Gann DS. Catecholamine activity in paraventricular hypothalamus after hemorrhage in cats. Am J Physiol Regul Integ Comparat Physiol 1989; 257:370-376.
23. Lam W, Gundlach AL, Verberne AJ. Neuronal activation in the forebrain following electrical stimulation of the cuneiform nucleus in the rat: hypothalamic expression of c-fos and NGFI-A messenger RNA. Neurosci 1997; 78:1069-1085.
24. Luna-Munguia H, Manuel-Apolinar L, Rocha L, Meneses A. 5-HT 1A receptor expression during memory formation. Psychopharmacol 2005; 181:309-318.
25. Shafei MN, Nikyar T, Hosseini M, Niazmand S, Paseban M. Cardiovascular effects of nitrergic system of the pedunculopontine tegmental nucleus in anesthetized rats. Iran J Basic Med Sci 2017; 20:776-781.
26. Paxinos G, Watson C. The rat brain in stereotaxix coordinates. Qingchuan Zhuge translate 2005;32: 98-106.
27. Pasandi H, Abbaspoor S, Shafei MN, Hosseini M, Khajavirad A. GABAA receptor in the Pedunculopontine tegmental (PPT) nucleus: Effects on cardiovascular system. Pharmacol Rep 2018; 70:1001-1009.
28. Helke C, McDonald C, Phillips E. Hypotensive effects of 5-HT1A receptor activation: ventral medullary sites and mechanisms of action in the rat. J Auton Nerv Syst 1993; 42:177-188.
29. Miyawaki T, Goodchild AK, Pilowsky PM. Rostral ventral medulla 5-HT1A receptors selectively inhibit the somatosympathetic reflex. Am J Physiol Regul Integ Comparat Physiol 2001; 280:1261-1268.
30. Verberne AJ. Cuneiform nucleus stimulation produces activation of medullary sympathoexcitatory neurons in rats. Am J Physiol 1995; 268:752-758.
31. Behbehani MM, Zemlan FP. Response of nucleus raphe magnus neurons to electrical stimulation of nucleus cuneiformis: role of acetylcholine. Brain Res 1986; 369:110-118.
32. Richter R, Behbehani M. Evidence for glutamic acid as a possible neurotransmitter between the mesencephalic nucleus cuneiformis and the medullary nucleus raphe magnus in the lightly anesthetized rat. Brain Res 1991; 544:279-286.
33. Portas CM, Thakkar M, Rainnie D, McCarley RW. Microdialysis perfusion of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the dorsal raphe nucleus decreases serotonin release and increases rapid eye movement sleep in the freely moving cat. J Neurosci 1996; 16:2820-2828.